Document Detail


Formulation and characterization of Brucea javanica oil microemulsion for improving safety.
MedLine Citation:
PMID:  23356859     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
Abstract Objective: This study engaged in investigation of optimal formulation, characteristics analysis of Brucea javanica oil microemulsion (BJOM) in order to address safety concerns and make recommendations for improvements in BJOM safety during clinical use in vivo. Methods: Pseudo-ternary phase diagram techniques were used to determine the appropriate ratio of surfactant, cosurfactant and oil phases. Subsequent stability testing of BJOM was performed by dilution, centrifugation and accelerated stability testing. The results were expounded through additional assessment utilizing the classical thermostat method to establish the shelf life of the material. These results were utilized to evaluate the safety of BJOM by haemolytic, irritative and allergic testing in vitro. In addition, the cytotoxicity of BJOM was examined using the tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT), with particular emphasis given to potential uses in cancer treatment. Results: The most suitable method of preparation for BJOM was found to be a one to one ratio (K(m) 1:1) of Solutol HS15 surfactant matched with sorbitol cosurfactant in the ratio. The microemulsion droplets of BJOM possessed a spherical shape, uniform size and average diameter of 23.8 nm. The expiration date of BJOM was found to be 568 d. The safety study demonstrated no hemolysis activity at the experimental BJOM concentrations; however, mild hemolysis was observed at higher concentrations of Brucea javanica oil emulsion (BJOE), a common commercially available product. Irritation observed upon BJOM treatment can be primarily attributed to Brucea javanica oil (BJO) with little influence of BJOM excipients. In addition, BJOM caused no observed hypersensitivity or other visible allergic reactions in guinea pigs. The anticancer activity curves of BJOM and BJOE demonstrate that both BJOM and BJOE inhibit Hela cells, with BJOM demonstrating significantly more dramatic anticancer activity. Conclusion: An optimal formulation of BJOM superior to commercially available products and safe for medical application such as intravenous injection has been outlined along with its anticancer activity rating.
Authors:
Fan Yang; Xiao Hong Yu; Fei Qiao; Li Hui Cheng; Gang Chen; Xiaoying Long; Xin Ran Wang; Xiao Li Li; Run Cheng Liang; Yan Zhong Chen
Related Documents :
16916089 - Quantitative indices for the assessment of the repeatability of distortion product otoa...
23259459 - Skin benefits with a novel emollient-treated menstrual pad.
23612449 - Assuring safety without animal testing: the case for the human testis in vitro.
7044779 - Psychophysical methods for the measurement of somatosensory dysfunction of laboratory a...
556679 - The evaluation of tests.
16475509 - Diagnosis of transmissible spongiform encephalopathies in animals: a review.
20397859 - The validity and reliability of a 6-metre timed walk for the functional assessment of p...
22079129 - Evaluation of specificity of tuberculosis diagnostic assays in caprine flocks under dif...
17719199 - Disgust sensitivity as a predictor of obsessive-compulsive contamination symptoms and a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2013-1-29
Journal Detail:
Title:  Drug development and industrial pharmacy     Volume:  -     ISSN:  1520-5762     ISO Abbreviation:  Drug Dev Ind Pharm     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-1-29     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7802620     Medline TA:  Drug Dev Ind Pharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Department of Pharmacy, Guangdong Pharmaceutical University , Guangzhou , People's Republic of China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Pharmacotherapy for Alcohol Dependence: Perceived Treatment Barriers and Action Strategies Among Vet...
Next Document:  Deformable liposomes by reverse-phase evaporation method for an enhanced skin delivery of (+)-catech...